Dianthus Therapeutics, Inc. /DE/ (DNTH)
Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoimmune diseases. Its lead clinical-stage candidate, claseprubart, a monoclonal antibody engineered with extended half-life, improved potency, and high selectivity for only the active C1s complement protein; and DNTH212, a bifunctional fusion protein that targets plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while simultaneously inhibiting BAFF/APRIL to suppress B cell function. Dianthus Therapeutics, Inc. was founded in 2019 and is headquartered in New York, New York.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Dianthus Therapeutics, Inc.
NASDAQ:DNTHHealthcare · Biotechnology
-0.39%$82.38
AH$82.38+0.00%vs close
Mkt Cap$4.61B
Float48.79M
O/S55.93M
Vol
$ Vol
RVOL
Inst Own-
SI18.4%
Earnings
Dilution
Financials Summary
Revenue$2.04M
Net Income-$162.34M
Total Assets$530.92M
Free Cash Flow-$129.27M
Debt & Equity
Debt 0%
Equity 100%
Total Debt$1.39M
Total Equity$493.4M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in DNTH's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$530.92M
Liabilities$37.52M
Accounts Receivable$102K
Accounts Payable$9.72M
Inventory$0
PP&E (Net)$1.63M
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
| Revenue | $2.04M | $6.24M | $2.83M | $6.42M | $1.48M | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | -67.3% | 120.6% | -56.0% | 334.8% | - | - | - | - | - | - |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 | $1.98M | $1.84M | $875K | $376K | $6K |
| Gross Profit | $2.04M | $6.24M | $2.83M | $6.42M | $1.48M | -$1.98M | -$1.84M | -$875K | -$376K | -$6K |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | - | - | - | - | - |
| Research and Development | $145.64M | $83.11M | $32.84M | $29.38M | $12.61M | $48.64M | $57.37M | $41.34M | $27.9M | $5.78M |
| Selling, General, and Administrative | $34.33M | $24.99M | $18.16M | $6.74M | $1.96M | $28.09M | $23.76M | $17.75M | $7.45M | $3.48M |
| Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $179.97M | $108.1M | $51M | $36.12M | $14.56M | $76.72M | $81.13M | $59.09M | $35.35M | $9.26M |
| Operating Income (EBIT) | -$177.93M | -$101.86M | -$48.17M | -$29.7M | -$13.09M | -$78.7M | -$82.97M | -$59.96M | -$35.73M | -$9.27M |
| Operating Margin | -8739.3% | -1633.7% | -1704.7% | -462.9% | -886.6% | - | - | - | - | - |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $3.77M | $0 | $0 | $0 | $163K |
| Interest Income | $16.12M | $17.36M | $4.76M | $1.15M | $100K | $3.77M | $0 | $2.45M | $236K | $0 |
| Other Income (Expense) | $15.6M | $16.89M | $4.62M | $1.23M | -$23K | $3.77M | $6.2M | $2.45M | $236K | -$163K |
| Income Before Tax (EBT) | -$162.34M | -$84.97M | -$43.55M | -$28.48M | -$13.11M | -$74.94M | -$76.77M | -$57.52M | -$35.49M | -$9.43M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $236K | $0 |
| Net Income | -$162.34M | -$84.97M | -$43.55M | -$28.48M | -$13.11M | -$74.94M | -$76.77M | -$57.52M | -$35.49M | -$9.43M |
| Net Income Margin | -7973.3% | -1362.8% | -1541.2% | -443.8% | -888.1% | - | - | - | - | - |
| Supplementary Data | ||||||||||
| EPS | -4.20 | -2.55 | -8.45 | -7.60 | -3.82 | -27.30 | -33.18 | -27.62 | -16.05 | -4.27 |
| Diluted EPS | -4.20 | -2.55 | -8.45 | -7.60 | -3.82 | -27.30 | -33.18 | -27.62 | -16.05 | -4.27 |
| Weighted Average OS | 37.79M | 33.31M | 5.15M | 3.75M | 3.43M | 2.75M | 2.31M | 2.08M | 2.21M | 2.21M |
| EBITDA | -$161.91M | -$84.56M | -$43.2M | -$28.33M | -$11.09M | -$72.96M | -$74.93M | -$56.64M | -$35.12M | -$9.26M |
| EBITDA Margin | -7952.3% | -1356.2% | -1528.7% | -441.5% | -751.3% | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
| Assets | ||||||||||
| Current Assets | ||||||||||
| Cash and Cash Equivalents | $51.09M | $22.79M | $132.32M | $15.37M | $131.65M | $58.15M | $65.07M | $58.34M | $51.57M | $4.54M |
| Short-Term Investments | $353.21M | $252.45M | $41.39M | $60.13M | $45.28M | $90.68M | $80.66M | $84.22M | $0 | $0 |
| Cash and Short-Term Investments | $404.3M | $275.24M | $173.72M | $75.49M | $176.93M | $148.84M | $145.73M | $142.57M | $51.57M | $4.54M |
| Accounts Receivable | $102K | $807K | $478K | $5.64M | $0 | $0 | $0 | $0 | $0 | $6.25M |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $5.04M | $355K | $504K | $53K | $3.77M | $2.69M | $4.11M | $2.75M | $936K | $41K |
| Total Current Assets | $409.44M | $280.9M | $177.45M | $82.03M | $180.69M | $151.53M | $149.84M | $145.32M | $52.5M | $10.83M |
| Long-Term Assets | ||||||||||
| Property, Plant & Equipment Net | $1.63M | $1.75M | $800K | $956K | $7.46M | $8.31M | $9.89M | $3.07M | $1.74M | $508K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $110.14M | $81.73M | $0 | $0 | $1.78M | $1.78M | $1.78M | $8.92M | $218K | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $9.72M | $9.63M | $1.15M | $121K | $0 | $0 | $0 | $0 | $4K | $0 |
| Total Long-Term Assets | $121.48M | $93.1M | $1.95M | $1.08M | $9.24M | $10.09M | $11.67M | $11.99M | $1.96M | $508K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $530.92M | $374.01M | $179.41M | $83.11M | $189.93M | $161.62M | $161.51M | $157.31M | $54.46M | $11.34M |
| Liabilities | ||||||||||
| Current Liabilities | ||||||||||
| Accounts Payable | $9.72M | $4.58M | $2.61M | $1.17M | $3.04M | $3.76M | $2.81M | $3.49M | $167K | $1.67M |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $1.19M | $479K | $100K | $100K | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $9.52M | $5.15M | $5.36M | $2.08M | $4.48M | $4.56M | $8.06M | $4.4M | $2.65M | $127K |
| Total Current Liabilities | $30.73M | $18.45M | $9.63M | $8.22M | $10.86M | $11.43M | $14.12M | $10.42M | $4.14M | $2.3M |
| Long-Term Liabilities | ||||||||||
| Long-Term Debt | $1.02M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $5.77M | $1.91M | $736K | $791K | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $6.4M | $6.28M | $6.21M | $1.25M | $0 | $0 |
| Total Long-Term Liabilities | $6.79M | $3.08M | $904K | $1.23M | $6.4M | $6.28M | $6.21M | $1.25M | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $37.52M | $21.53M | $10.54M | $9.45M | $17.26M | $17.71M | $20.32M | $11.66M | $4.14M | $2.3M |
| Stockholders' Equity | ||||||||||
| Preferred Stock | $0 | $0 | $0 | $118.02M | $0 | $0 | $0 | $0 | $92.44M | $17.92M |
| Common Stock | $43K | $31K | $15K | $0 | $59K | $49K | $39K | $33K | $6K | $3K |
| Retained Earnings | -$336.73M | -$174.39M | -$89.42M | -$45.87M | -$325.57M | -$254.43M | -$179.5M | -$102.73M | -$45.21M | -$9.72M |
| Comprehensive Income & Other | $489K | $106K | $47K | -$161K | -$30K | -$23K | $8K | -$8K | -$382K | -$6K |
| Other Stockholders' Equity | $830.09M | $526.84M | $258.28M | $119.52M | $498.18M | $398.29M | $320.65M | $248.34M | $95.53M | $18.76M |
| Total Equity | $493.4M | $352.48M | $168.87M | $73.66M | $172.67M | $143.91M | $141.19M | $145.65M | $50.32M | $9.04M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $530.92M | $374.01M | $179.41M | $83.11M | $189.93M | $161.62M | $161.51M | $157.31M | $54.46M | $11.34M |
| Supplementary Data | ||||||||||
| Total Debt | $1.39M | $1.49M | $585K | $788K | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Debt | -$49.7M | -$21.3M | -$131.74M | -$14.58M | -$131.65M | -$58.15M | -$65.07M | -$58.34M | -$51.57M | -$4.54M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
| Operating Activities | ||||||||||
| Net Income | -$162.34M | -$84.97M | -$43.55M | -$28.48M | -$71.14M | -$74.94M | -$76.77M | -$57.52M | -$35.49M | -$9.43M |
| Depreciation & Amortization | $428K | $412K | $355K | $147K | $2.02M | $1.98M | $1.84M | $875K | $376K | $6K |
| Deferred Income Tax | $0 | $0 | -$661K | $0 | $0 | -$12.95M | -$13.54M | $0 | $0 | $0 |
| Stock-Based Compensation | $22.79M | $12.89M | $2.9M | $1.52M | $0 | $0 | $0 | $0 | $2.26M | $662K |
| Changes in Working Capital: | ||||||||||
| Accounts Receivable | $755K | $0 | $5.16M | -$4.16M | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $11.28M | $8.19M | $661K | $2.28M | -$720K | $948K | $145K | $2.5M | -$1.13M | $1.01M |
| Other Working Capital | $4.69M | -$8.54M | -$959K | $229K | -$806K | -$2.13M | $8.69M | $1.48M | $2.44M | $590K |
| Total Working Capital Change | $16.73M | -$351K | $4.86M | -$1.65M | -$1.53M | -$1.19M | $8.83M | $3.98M | $1.32M | $1.6M |
| Other Non-Cash Items | -$6.67M | -$6.17M | -$762K | -$606K | $11.11M | $23.07M | $22.53M | $10.02M | $13.41M | $306K |
| Net Cash from Operating | -$129.06M | -$78.18M | -$36.86M | -$29.07M | -$59.53M | -$64.02M | -$57.1M | -$41.89M | -$22.26M | -$6.53M |
| Investing Activities | ||||||||||
| Capital Expenditures | -$213K | -$105K | -$110K | -$139K | -$1.26M | -$400K | -$3.06M | -$7.67M | -$2.2M | -$139K |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $12K | $0 | $0 |
| Purchases of Investments | -$435.01M | -$413.71M | -$57.42M | -$61.68M | -$45.31M | -$95.73M | -$144.37M | -$84.04M | $0 | $0 |
| Sales of Investments | $312.39M | $127M | $77.78M | $2M | $90M | $85.5M | $148.96M | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $12K | -$135K | $0 |
| Net Cash from Investing | -$122.83M | -$286.81M | $20.25M | -$59.82M | $43.43M | -$10.63M | $1.53M | -$91.7M | -$2.2M | -$139K |
| Financing Activities | ||||||||||
| Debt Repaid | - | - | - | - | - | - | - | - | - | -$6.5M |
| Common Stock Issuance | $280.13M | $269.2M | $72M | $0 | $89.6M | $67.74M | $62.3M | $142.15M | $71.49M | $4.21M |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$88K | -$213K | -$107K |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | -$13.57M | $61.57M | -$3.32M | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Financing | $280.13M | $255.62M | $133.57M | $96.68M | $89.6M | $67.74M | $62.3M | $142.15M | $71.49M | $10.71M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $28.23M | -$109.37M | $116.97M | $7.79M | $73.5M | -$6.92M | $6.73M | $6.78M | $47.02M | $4.04M |
| Supplementary Data | ||||||||||
| Operating Cash Flow | -$129.06M | -$78.18M | -$36.86M | -$29.07M | -$59.53M | -$64.02M | -$57.1M | -$41.89M | -$22.26M | -$6.53M |
| Capital Expenditure | -$213K | -$105K | -$110K | -$139K | -$1.26M | -$400K | -$3.06M | -$7.67M | -$2.2M | -$139K |
| Free Cash Flow | -$129.27M | -$78.28M | -$36.97M | -$29.21M | -$60.8M | -$64.42M | -$60.16M | -$49.56M | -$24.46M | -$6.67M |
| Cash at Beginning | $23.02M | $132.39M | $15.43M | $7.64M | $58.15M | $65.07M | $58.34M | $51.57M | $4.54M | $500K |
| Cash at End | $51.25M | $23.02M | $132.39M | $15.43M | $131.65M | $58.15M | $65.07M | $58.34M | $51.57M | $4.54M |